FDA DEVICE FACTS
VANISH PRO
Ddc Technologies, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The VANISH PRO is intended for the treatment of benign vascular lesions, benign pigmented lesions, and for tattoo removal and the incision, excision, ablation, vaporization of soft tissue for General dermatology such as, but not limited to treatment of: 1064 nm in QS and PTM Modes:
• Tattoo removal of black, brown, blue, and brown inks
• Removal of benign pigmented lesions
• Treatment of Melasma
• Treatment of Nevus of Ota
• Treatment of Common Nevi, Becker’s Nevi
• Treatment of Café au Lait macules (CALMs)
• Skin resurfacing procedures for the treatment of acne scars and wrinkles. 532 nm in QS and PTM Modes:
• Tattoo removal of red, tan, purple, blue, yellow, and orange ink
• Treatment of Café au Lait macules (CALMs)
• Treatment of Lentigines
• Removal of epidermal pigmented lesions
• Removal of minor vascular lesions
• Skin resurfacing procedures for the treatment of acne scars and wrinkles.
• Treatment of seborrheic keratosis
• Treatment of Freckles and Nevi Spilus
• Treatment of post inflammatory hyperpigmentation
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。